Tag Archives: Avastin

Phase III Trial of Bevacizumab with Chemotherapy

A Phase III trial of bevacizumab (Avastin) with gemcitabine + carboplatin versus gemcitabine + carboplatin in women with ovarian cancer showed the bevacizumab arm to improve progression free survival (PFS). … Continue reading 

Posted in News | Also tagged , , , , , | Leave a comment

Cost-Effective Analysis of Bevacizumab for Ovarian Cancer

A study published in the Journal of Clinical Oncology concludes that “[t]he addition of bevacizumab to standard chemotherapy in patients with advanced ovarian cancer is not cost effective.” The study … Continue reading 

Posted in News | Also tagged , , , | Leave a comment

Update on Medicare Coverage for Avastin (bevacizumab)

Months ago, we told you about a Medicare contractor who was denying coverage of Avastin for patients with ovarian cancer. The Ovarian Cancer National Alliance has worked with Members of … Continue reading 

Posted in Blog, News | Also tagged , , , | Leave a comment